Original Research
Accepted on 12 Feb 2026
Modeling rebound bone loss following denosumab discontinuation and sequential zoledronate therapy in TgRANKL osteoporotic mice
in Bone Research
Original Research
Accepted on 12 Feb 2026
in Bone Research
Original Research
Accepted on 12 Feb 2026
in Psychological Therapy and Psychosomatics
Original Research
Accepted on 12 Feb 2026
in Astrobiology
Correction
Accepted on 12 Feb 2026
in Infectious Agents and Disease
Original Research
Accepted on 12 Feb 2026
in Microbial Symbioses
Original Research
Accepted on 12 Feb 2026
in Media Psychology
Systematic Review
Accepted on 12 Feb 2026
in Ophthalmology
Review
Accepted on 12 Feb 2026
in Clinical Nutrition
Review
Accepted on 12 Feb 2026
in Antibiotic Resistance and New Antimicrobial drugs
Review
Accepted on 12 Feb 2026
in Environmental Toxicology
Review
Accepted on 12 Feb 2026
in Vaccines and Molecular Therapeutics
Original Research
Accepted on 12 Feb 2026
in Extreme Microbiology
Original Research
Accepted on 12 Feb 2026
in Land, Livelihoods and Food Security
Original Research
Accepted on 12 Feb 2026
in Clinical Nutrition
Original Research
Accepted on 12 Feb 2026
in Water Resource Management
Editorial
Accepted on 12 Feb 2026
in Radiomics and Artificial Intelligence